| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.058 | 15.714 | 19.720 | 19.032 | 17.727 | 17.850 | 20.957 | 22.241 | 27.827 | 29.572 |
| Total Income - EUR | 15.098 | 15.719 | 19.724 | 19.039 | 17.732 | 17.855 | 21.236 | 22.244 | 27.835 | 29.577 |
| Total Expenses - EUR | 12.015 | 14.034 | 3.747 | 3.968 | 5.256 | 5.807 | 7.375 | 6.789 | 10.836 | 11.295 |
| Gross Profit/Loss - EUR | 3.083 | 1.685 | 15.977 | 15.071 | 12.476 | 12.048 | 13.861 | 15.455 | 16.999 | 18.282 |
| Net Profit/Loss - EUR | 2.629 | 1.330 | 15.385 | 14.500 | 11.944 | 11.527 | 13.224 | 14.801 | 16.726 | 18.021 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Proremed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 899 | 1.010 | 993 | 975 | 1.511 | 3.662 | 3.203 | 2.834 | 2.448 | 2.059 |
| Current Assets | 23.154 | 23.338 | 38.386 | 37.312 | 47.434 | 42.609 | 55.335 | 30.076 | 30.006 | 48.250 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.730 | 4.805 | 11.681 | 18.788 | 21.587 | 31.567 | 18.214 | 12.106 | 15.360 | 30.688 |
| Cash | 19.424 | 18.533 | 26.706 | 18.524 | 25.846 | 11.042 | 37.121 | 17.969 | 14.645 | 17.562 |
| Shareholders Funds | 23.013 | 24.109 | 39.086 | 37.766 | 34.759 | 45.627 | 57.839 | 32.264 | 31.532 | 49.377 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 1.040 | 240 | 293 | 521 | 14.185 | 643 | 699 | 646 | 921 | 932 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3313 - 3313" | |||||||||
| CAEN Financial Year |
3313
|
|||||||||
Comments - Proremed S.r.l.